| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 10/05/2006 | US20060223773 RNAi-mediated inhibition of Frizzled Related Protein-1 for treatment of glaucoma |
| 10/05/2006 | US20060223772 Vectors comprising guinea pig CMV regulatory elements |
| 10/05/2006 | US20060223770 IRNA agents targeting VEGF |
| 10/05/2006 | US20060223768 Regulation of gene expression |
| 10/05/2006 | US20060223767 Vector for gene therapy and method of quantifying target protein in mammal or cultured cells with the administration of the vector for gene therapy |
| 10/05/2006 | US20060223757 Applications in gene therapy, transgenic organisms, functional genomics, and other areas of cell and molecular biology. |
| 10/05/2006 | US20060223755 biodrug having affinity to bacterial and fungal toxins, and especially to lipopolysaccharide or lipoteichoic acid; treating a fungal or bacterial infection; ear infection, upper respiratory infection, sinusitis, otitis |
| 10/05/2006 | US20060223754 Human TSLP polynucleotides |
| 10/05/2006 | US20060223752 Of pestviruses as drug delivery devices for type-specific diagnosis of infection, for eliciting antibiotic activity, and for transport of substances into a cell |
| 10/05/2006 | US20060223186 Double transposition methods for manipulating nucleic acids |
| 10/05/2006 | US20060223185 applying electric field and an acoustic wave to induce electroporation in the cell; for extracting and injecting materials into living cells with a high level of predictability and accuracy |
| 10/05/2006 | US20060223184 Supports useful in incorporating biomolecules into cells and methods of using thereof |
| 10/05/2006 | US20060223183 Gamma irradiation of frozen feeder cells |
| 10/05/2006 | US20060223158 Regulation of neuronal function through metabotropic glutamate receptor signaling pathways |
| 10/05/2006 | US20060223151 Production of polyketides |
| 10/05/2006 | US20060223149 Methods for producing sulphurous fine chemicals |
| 10/05/2006 | US20060223148 Process for sequence saturation mutagenesis (sesam) |
| 10/05/2006 | US20060223145 Method for producing recombinant human interferon alpha 2b polypeptide in pichia pastoris |
| 10/05/2006 | US20060223144 Method for mass production of human pollicle stimulating hormone |
| 10/05/2006 | US20060223143 Methods and compositions for polypeptide engineering |
| 10/05/2006 | US20060223142 Extended cDNAs for secreted proteins |
| 10/05/2006 | US20060223141 Transcription amplification system for molecular imaging |
| 10/05/2006 | US20060223136 Scytalone dehydrogenase gene showing tolerance to agricultural pesticide |
| 10/05/2006 | US20060223133 Comprises immunoglobulin for treating arteriosclerosis, cancer and skin disorders; immunoassays; restenosis |
| 10/05/2006 | US20060223121 Contacting biological sample of urine, cerebrospinal fluid or serum with a peptide and complexing with a monoclonal antibody ligand; detecting an immunogenic peptide having calgranulin B protein activity; Alzheimer's and Parkinson's disease, amyotrophic lateral sclerosis; rheumatoid arthritis |
| 10/05/2006 | US20060223115 Heterotrimeric G-protein |
| 10/05/2006 | US20060223105 Mass spectrometric methods for detecting mutations in a target nucleic acid |
| 10/05/2006 | US20060223089 Reverse two-hybrid systems |
| 10/05/2006 | US20060223082 Map |
| 10/05/2006 | US20060223067 Mutant DNA polymerases and methods of use |
| 10/05/2006 | US20060223065 Diagnostic and therapeutic use of a sulfotransferase for neurodegenerative diseases |
| 10/05/2006 | US20060223063 Method of diagnosis of type 2 diabetes and early onset thereof |
| 10/05/2006 | US20060223057 Nucleic acid sequences that can be used as primers and probes in the amplification and detection of all subtypes of HIV-1 |
| 10/05/2006 | US20060223056 Nucleic acid sequences that can be used as primers and probes in the amplification and detection of all subtypes of HIV-1 |
| 10/05/2006 | US20060223055 Methods and compositions for treatment of viral lnfection |
| 10/05/2006 | US20060223054 Methods for identifying a peptide that binds a geometrical shape |
| 10/05/2006 | US20060222696 comprising one or more phosphatidylcholines, an N-( omega )-dicarboxylic acid-derivatized phosphatidyl ethanolamine, a targeting factor-modified N-( omega )-dicarboxylic acid-derivatized phosphatidyl ethanolamine, an encapsulated drug, cholesterol; cancer treatment |
| 10/05/2006 | US20060222666 Clostridial toxin derivatives and methods for treating pain |
| 10/05/2006 | US20060222665 Virus vaccine |
| 10/05/2006 | US20060222664 Transforming tobacco cell line containing sequences encoding antigens (such as hemagglutinin/neuraminidase protein from Newcastle Disease Virus), culturing, washing, suspending in lysis buffer, disrupting cells, then separating debris; vaccines |
| 10/05/2006 | US20060222663 Circovirus sequences associated with piglet weight loss disease (PWD) |
| 10/05/2006 | US20060222661 Infectious hepacivirus pseudo-particles containing functional e1, e2 envelope proteins |
| 10/05/2006 | US20060222658 Vaccinia virus nucleic acids, polypeptides and immunogenic compositions |
| 10/05/2006 | US20060222652 Molecular antigen array |
| 10/05/2006 | US20060222649 Methods for inducing antigen-specific T cell tolerance |
| 10/05/2006 | US20060222644 Humanized anti-Lymphotoxin beta receptor antibodies |
| 10/05/2006 | US20060222638 Cholesterol biosynthesis pathway modulators and uses thereof |
| 10/05/2006 | US20060222636 Compositions, methods and kits relating to reprogramming adult differentiated cells and production of embryonic stem cell-like cells |
| 10/05/2006 | US20060222635 Methods and compositions for selecting cells with increased potency |
| 10/05/2006 | US20060222631 Methods for therapeutic use of brain derived neurotrophic factor in the entorhinal cortex |
| 10/05/2006 | US20060222630 Internal ribosome entry site of the labial gene for protein expression |
| 10/05/2006 | US20060222629 Compositions and methods for delivery of genetic material |
| 10/05/2006 | US20060222624 Detoxified TNF and method of preparing |
| 10/05/2006 | US20060219639 Novel separation agent for separating optical isomer and method for preparation thereof |
| 10/05/2006 | DE102005013846A1 Identifizierung von Oberflächen-assoziierten Antigenen für die Tumordiagnose und -therapie Identifying surface-associated antigens for tumor diagnosis and therapy |
| 10/05/2006 | CA2603730A1 Inhibitors of ribonucleotide reductase subunit 2 and uses thereof |
| 10/05/2006 | CA2603379A1 Cloning and characterization of micrornas from rice |
| 10/05/2006 | CA2603325A1 Methods for lowering the level of tumor necrosis factor (tnf) in tnf-associated disorders |
| 10/05/2006 | CA2603298A1 Tuberculosis vaccine and method for making same |
| 10/05/2006 | CA2603205A1 Gene synthesis using pooled dna |
| 10/05/2006 | CA2603151A1 Identification of a sterol acyltransferase gene |
| 10/05/2006 | CA2603052A1 Immunogenic egfr peptides comprising foreign t cell stimulating epitope |
| 10/05/2006 | CA2602843A1 Stress tolerant transgenic plants over-expressing genes of ascorbic acid synthesis-cell wall |
| 10/05/2006 | CA2602709A1 Isolation of inhibitor of ires-mediated translation |
| 10/05/2006 | CA2602539A1 Monoclonal antibodies specific to denatured human class 1 leukocyte antigens |
| 10/05/2006 | CA2602463A1 High affinity hiv t cell receptors |
| 10/05/2006 | CA2602337A1 Eg1117 and eg307 polynucleotides and uses thereof |
| 10/05/2006 | CA2602156A1 Expression cassettes for seed-preferential expression in plants |
| 10/05/2006 | CA2600989A1 Phosphorylated waxy potato starch |
| 10/05/2006 | CA2599988A1 Methods and compositions for modulating hyperstabilized c-met |
| 10/05/2006 | CA2598884A1 Influenza nucleic acids, polypeptides, and uses thereof |
| 10/05/2006 | CA2593559A1 Polynucleotides encoding stem cell factor-like proteins |
| 10/04/2006 | EP1707642A2 Method for detecting cytosine methylations |
| 10/04/2006 | EP1707641A2 Evolution of whole cells and organisms by recursive sequence recombination |
| 10/04/2006 | EP1707638A1 Method of multiplex microorganism detection |
| 10/04/2006 | EP1707637A1 Method of judging clinical malignancy of fals |
| 10/04/2006 | EP1707633A1 Alphavirus vectors for paramyxovirus vaccines |
| 10/04/2006 | EP1707632A1 Phosphorylated waxy potato starch |
| 10/04/2006 | EP1707631A2 An improved method for the production and purification of adenoviral vectors |
| 10/04/2006 | EP1707630A1 Antisense oligonucleotide having anticancerous activity |
| 10/04/2006 | EP1707629A1 Expression system with the use of mammalian beta-actin promoter |
| 10/04/2006 | EP1707628A1 Methods for producing recombinant polyclonal immunoglobulins |
| 10/04/2006 | EP1707627A1 Mutants of anti-cd40 antibody |
| 10/04/2006 | EP1707626A1 Gene amplification method |
| 10/04/2006 | EP1707622A1 Use of compounds that regulate hdac6 tubulin deacetylase activity in the preparation of pharmaceutical compositions, method of identifying the aforementioned regulating compounds, said pharmaceutical compounds and applications thereof |
| 10/04/2006 | EP1707621A2 Mutant bioluminescent protein, and process for producing the mutant bioluminescent protein |
| 10/04/2006 | EP1707193A2 Pharmaceutical composition for the prophylaxis and/or treatment of viral diseases |
| 10/04/2006 | EP1707055A2 Enhanced production of lipids containing polyenoic fatty acids by very high density cultures of eukaryotic microbes in fermentors |
| 10/04/2006 | EP1707051A2 Pluripotent cells having disrupted endogenous genes |
| 10/04/2006 | EP1706826A2 Methods for placing, accepting, and filling orders for products and services |
| 10/04/2006 | EP1706739A1 Bioluminescent assays and cells useful therein |
| 10/04/2006 | EP1706511A2 Compositions and methods for generating short double-stranded rna using mutated rnase iii |
| 10/04/2006 | EP1706506A1 A sensitive and specific test to detect sars coronavirus |
| 10/04/2006 | EP1706501A2 Biochemical synthesis of 6-amino caproic acid |
| 10/04/2006 | EP1706499A2 Human cytomegalovirus us3 gene promoter |
| 10/04/2006 | EP1706498A2 Tools and methods useful in characterising the immunotoxic activity of xenobiotic substances |
| 10/04/2006 | EP1706497A1 Two-component rna virus- derived plant expression system |
| 10/04/2006 | EP1706496A2 Enhanced expression |
| 10/04/2006 | EP1706495A1 Method for producing carotenoids and bacteria used therefor |
| 10/04/2006 | EP1706494A2 Method for production of recombinant growth hormone in form of hybrid protein |